Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/110925
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVizoso, Miguel-
dc.contributor.authorFerreira, Humberto J.-
dc.contributor.authorLópez Serra, Paula-
dc.contributor.authorCarmona, F. Javier-
dc.contributor.authorMartínez Cardús, Anna-
dc.contributor.authorGirotti, Maria Romina-
dc.contributor.authorVillanueva Garatachea, Alberto-
dc.contributor.authorGuil, Sonia-
dc.contributor.authorMoutinho, Cátia-
dc.contributor.authorLiz, Julia-
dc.contributor.authorPortela, Anna-
dc.contributor.authorHeyn, Holger-
dc.contributor.authorMoran, Sebastian-
dc.contributor.authorVidal-Bel, August-
dc.contributor.authorMartínez Iniesta, María-
dc.contributor.authorManzano, José Luis-
dc.contributor.authorFernandez-Figueras, Maria Teresa-
dc.contributor.authorÉlez, Elena-
dc.contributor.authorMuñoz-Couselo, Eva-
dc.contributor.authorBotella-Estrada, Rafael-
dc.contributor.authorBerrocal, Alfonso-
dc.contributor.authorPontén, Fredrik-
dc.contributor.authorOord, Joost van den-
dc.contributor.authorGallagher, William M.-
dc.contributor.authorDenFrederick, Dennie T.-
dc.contributor.authorFlaherty, Keith T.-
dc.contributor.authorMcDermott, Ultan-
dc.contributor.authorLorigan, Paul-
dc.contributor.authorMarais, Richard-
dc.contributor.authorEsteller, Manel-
dc.date.accessioned2017-05-12T10:22:40Z-
dc.date.available2017-05-12T10:22:40Z-
dc.date.issued2015-06-01-
dc.identifier.issn1078-8956-
dc.identifier.urihttp://hdl.handle.net/2445/110925-
dc.description.abstractMetastasis is respoMetastasis is responsible for most cancer-related deaths, and, among common tumor types, melanoma is one with great potential to metastasize. Here we study the contribution of epigenetic changes to the dissemination process by analyzing the changes that occur at the DNA methylation level between primary cancer cells and metastases. We found a hypomethylation event that reactivates a cryptic transcript of the Rab GTPase activating protein TBC1D16 (TBC1D16-47 kDa; referred to hereafter as TBC1D16-47KD) to be a characteristic feature of the metastatic cascade. This short isoform of TBC1D16 exacerbates melanoma growth and metastasis both in vitro and in vivo. By combining immunoprecipitation and mass spectrometry, we identified RAB5C as a new TBC1D16 target and showed that it regulates EGFR in melanoma cells. We also found that epigenetic reactivation of TBC1D16-47KD is associated with poor clinical outcome in melanoma, while conferring greater sensitivity to BRAF and MEK inhibitors.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1038/nm.3863-
dc.relation.ispartofNature Medicine, 2015, vol. 21, num. 7, p. 741-750-
dc.relation.urihttps://doi.org/10.1038/nm.3863-
dc.rights(c) Vizoso, Miguel et al., 2015-
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)-
dc.subject.classificationMelanoma-
dc.subject.classificationMetàstasi-
dc.subject.classificationEpigènesi-
dc.subject.classificationMetilació-
dc.subject.classificationProteïnes supressores de tumors-
dc.subject.otherMelanoma-
dc.subject.otherMetastasis-
dc.subject.otherEpigenesis-
dc.subject.otherMethylation-
dc.subject.otherTumor suppressor protein-
dc.titleEpigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec654150-
dc.date.updated2017-05-12T10:22:40Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid26030178-
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
654150.pdf4.22 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.